References
- Staub A M, Bovet D. Action de la thymoxethyldiethy-amine (939F) et des ethers phenoliques sur le choc anaphylactique du cobaye. R Soc Biol 1937; 125: 818–23
- Simons F ER, Simons KJ. H1-receptor antagonist treatment of chronic rhinitis. J Allergy Clin Immunol 1988; 81: 975–80
- Rimmer S J, Church MK. The pharmacology and mechanisms of action of histamine H,-antagonists. Clin Exp Allergy 1990; 20: 3–17, Suppl 2
- Howarth P H, Holgate ST. Comparative trial of two non-sedative H, antihistamines, terfenadine and astemi-zole, for hay fever. Thorax 1984; 39: 668–72
- Naclerio R M, Togias AG. The nasal allergic reaction: observations on the role of histamine. Clin Exp Allergy 1991; 21: 13–9, Suppl 2
- Shelton D, Eiser N. Histamine receptors in the human nose. Clin Otolaryngol 1994; 19: 45–9
- Pipkorn U. Allergic rhinitis-Diagnosis and treatment. Allergy., ST Holgate, MR Church. Gower Medical Publishing, London 1993; 18–1–18.10
- Wang D Y, Clement P, Smitz J, De Waele M, Derde M-P. Correlations between complaints, inflammatory cells and mediators after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol 1995; 106: 278–85
- Clement P AR, Van Dishoeck A, Van de Wal J, Stoop P, Hoek T, Van Strick R. Nasal provocation and passive anterior rhinomanometry (PAR). Clin Allergy 1981; 11: 293–301
- Biewenga J, Stoop A E, Baker H E, et al. Nasal secretions from patients with polyps and healthy individuals, collected with a new aspiration system: evaluation of total protein and immunoglobulin concentrations. Ann Clin Biochem 1991; 28: 260–6
- Wang D Y, Clement P, Smitz J, Derde M-P. Concentrations of chemical mediators in nasal secretions of patients with hay fever during natural allergen exposure. Acta Otolarynol (Stockh) 1994; 114: 552–5
- Van Wijk Gerth R., Dieges PH. Comparison of nasal responsiveness to histamine, methacholine and phento-lamine in allergic rhinitis patients and controls. Clin Allergy 1987; 17: 563–70
- Connell JT. Quantitative intranasal pollen challenge III. the priming effect in allergic rhinitis. J Allergy 1969; 43: 33–8
- Campoli-Richards D, Buckley M, Fitton A. Cetirizine —A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Drugs 1990; 40: 762–81
- Testa B, Mesolella C, Filippini P, Campagnano N, Testa D, Mesolella M, Sagnelli E. The role of H, antagonists in perennial allergic rhinitis. Laryngoscope 1993; 103: 1013–9
- Carpenter G B, Bunker-Soler A L, Nelson HS. Evaluation of combined Hr and H2-receptor blocking agents in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1983; 71: 412–7
- Dachman W D, Bedarida G, Blaschke T F, Hoffman BB. Allergens, IgE, mediators, inflammatory mechanisms. J Allergy Clin Immunol 1994; 93: 606–14
- Settipane G. Chronic rhinitis: an updated clinical review. Am I Rhinol 1991; 5: 199–206
- Brooks C D, Butler D, Metzler C. Effect of H2 blockade in the challenged allergic nose. J Allergy Clin Immunol; 1982; 70: 373–6